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Direct antigen binding to glomerular immune complex deposits. We
evaluated the contribution of intrarenal factors in the increased renal
accumulation of bovine serum albumin (BSA) in chronic serum sickness
(CSS). Renal transplantation was used to study 125J BSA uptake (single
and paired label techniques) in normal and CSS kidneys exposed to the
same immunologic milieu. In CSS, the daily dose of BSA (dose 15 to
150 mg) was substituted with radiolabeled BSA. Uptake in washed
kidney homogenates (24 hours) in the recipient's native CSS kidney
varied from 0.29 to 38.40 g/g of kidney (mean 11.70) compared to 0.09
to 2.19 g/g (mean 1.01) in the transplanted normal kidney. The ratio of
uptake in the CSS/normal kidney varied from 2.1 to 17.5. These findings
indicated that intrarenal factors were important in renal uptake since
both kidneys had been exposed to the same circulating immune
complex load. Transplantation between "early" (nonproteinuric) and
late (proteinuric) CSS rabbits again suggested intrarenal factors influ-
ence the uptake of 125J BSA immune complex components with late
CSS kidney/early CSS kidney uptake ratios of 25 and 49 in the pairs
examined. When CSS kidneys were transplanted into normal rabbits,
the binding of ito 160 mg of radiolabeled BSA in the transplanted CSS
kidney varied from 0.68 to 22.89 ,aglg (mean 7.15) compared to 0.01 to
0.84 ,g/g (mean 0.18) in the normal rabbit's native kidney. The uptake
in the CSS kidney always exceeded that in the recipient's normal
kidney (ratio varied from 18 to 289). The binding of radiolabeled BSA in
the CSS kidney was quantitatively similar to that found previously in
the intact CSS rabbit. This suggests that dynamic interchange of antigen
and presumably antibody is involved in the accumulation of immune
complexes in the CSS rabbit.
Serum sickness in rabbits is a classic model of immune
complex disease with glomerulonephritis [1—3]. Large single or
smaller daily injections with native bovine serum albumin
(BSA) lead to acute or chronic serum sickness (CSS) models,
respectively, with circulating immune complexes and renal
(glomerular, interstitial) and extrarenal vascular accumulations
of immune complex material [4]. The dynamics of antigen!
antibody interaction within the predominately glomerislar im-
mune complex deposits in these models is suggested by the
continued binding of antibody detected by immunofluores-
cence after immune elimination or by administration of exoge-
nous radiolabeled anti-BSA antibody in the acute disease [5—71.
Large excesses of antigen can quantitatively dissolve glomeru-
lar immune complexes when administered to rabbits with CSS
[81. The present experiment was designed to explore the possi-
ble contribution of the dynamic interchange of antigen with
previously deposited immune complexes in the rapid accumu-
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lation of the renal immune complex material that occurs after
four to five weeks of daily injection in the CSS model [8].
Prior quantitative studies had shown that the localization of
radiolabeled BSA in renal immune complex deposits was only
0.03 percent of the daily injected dose (10 to 200 mg chosen to
balance antibody production) during the initial four to six weeks
of immunization required to develop proteinuric CSS glomeru-
lonephritis [8]. Somewhat before or coincident with the onset of
proteinuric glomerulonephritis, the renal localization of radio-
labeled BSA antigen increased dramatically to about 0.5% of
the daily dose. This quantitative increase correlated with chang-
ing patterns of BSA, IgG and C3 deposits from a scattered,
predominantly mesangial location into a heavy subepithelial
glomerular capillary wall deposit. The reasons for this increased
immune complex accumulation could be either extrarenal and
related to the characteristics of the circulating immune reac-
tants and their clearance, or they could be intrarenal in nature.
In terms of the former, the striking renal accumulation occurred
without any detected differences in the quantities of circulating
antibody or quantities and size of circulating immune com-
plexes. The increase did coincide with an increase in antibody
avidity that occured progressively during the period of antigen
injection. To examine whether or not intrarenat factors might be
responsible for the increased localization, transplantation was
used to create a situation in which a normal kidney or an early
CSS kidney was placed in a rabbit with advanced proteinuric
CSS glomerulonephritis. The quantitative localization of radio-
labeled antigen could then be determined and compared in each
kidney. An increased uptake by the CSS kidney would suggest
that intrarenal factors such as the interaction of BSA and
BSA-anti-BSA complexes with previously deposited immune
complex material might contribute to the accelerated immune
complex localization at this stage of the disease.
Methods
Experimental protocol
Non-syngeneic male New Zealand white rabbits (2.5 to 3.5
kg) from a single vendor were used throughout. Rabbits with
spontaneous proteinuria [91 >10 mg/24 hr were excluded. CSS
was induced by daily intravenous injection of BSA (Reheis
Chemical Co., Phoenix, Arizona, USA) in sterile saline, ini-
tially in a dose of 10 mg/day. Circulating anti-BSA antibody
levels were determined weekly by the radioactive precipitin
method, and BSA dosage was adjusted weekly to balance
antibody production as previously described [81. Proteinuria
was quantitated weekly by a sulfosalicylic acid method to
detect the onset of overt nephritis [6].
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Twenty—two transplants were performed. In Group A (seven
cases), the kidney was transplanted from a normal donor to a
CSS recipient, in Group B (10 cases) from a CSS donor to a
normal recipient, and in Group C (five cases) transplantation
was between CSS rabbits at different stages in the evolution of
their glomerulonephritis. In all cases, CSS rabbits received
their last daily intravenous dose of BSA 24 hours prior to the
transplantation operation. In some instances, the donor also
was given a similar 131J BSA (24 hours before organ harvest) so
that plasma levels and kidney uptakes could be determined.
Each donor rabbit was anesthetized with intravenous barbitu-
rate, and the left kidney was removed together with a segment
of aorta and vena cava. The kidney was perfused clean with an
intraarterial perfusion of cold sterile saline, and was kept in
ice—cold sterile saline until transplanted (not more than 30
minutes). After harvest, donors were sacrificed and samples of
the right kidney and other organs were taken for routine
histology, immunofluorescence microscopy, and where appro-
priate, for quantitation of BSA uptake. Recipients were anes-
thetized; the donor kidney to be transplanted was placed in the
right lower abdomen and anastomosed end—to—side to the
recipient's aorta and vena cava. The donor ureter was re-
implanted into the recipient bladder. Before closure of the
laparotomy, a left nephrectomy was performed and the kidney
samples processed as described above.
Quantitation of circulating and renal-bound BSA
Twenty—four hours prior to sacrifice (which was 36 to 72
hours after transplantation), the recipient rabbits were given an
intravenous injection of 131J or 1251 BSA (*1 BSA). The dose was
selected arbitrarily when the recipient was a normal rabbit, or
was chosen to be sufficient to match measured circulating
anti-BSA antibody levels when the recipient was a CSS rabbit.
131j rabbit serum albumin (RSA) was injected concurrently in an
equal dose to serve as a paired—label control [6, 8], except when
131J BSA had been used previously in the donor to determine the
uptake of BSA in the donor kidney.
Plasma samples were taken at 10 minutes, one hour, three
hours, and 24 hours following *1 BSA injections. Total
protein—bound 131j and 125J counts (10% TCA precipitates) and
immune—complexed *1 BSA in washed 50% saturated ammo-
nium sulfate precipitates were quantitated [6, 81.
Transplanted rabbits were sacrificed with an overdose of
barbiturate. The transplanted kidney was then examined in situ
with reference to its appearance, the vascular anastomoses, and
the ureteric drainage. Each native and transplanted kidney was
weighed, a median slice was divided for routine microscopy and
immunofluorescence microscopy, and the residual two halves
were frozen. For quantitation the frozen half kidneys were
weighed, then homogenized, and washed three times as previ-
ously described [6, 8]; the washed homogenates were counted
and the uptake of each radiolabelled protein was calculated as
micrograms of protein per gram original kidney. In cases where
131J BSA studies were done in the donor prior to transplanta-
tion, contralateral kidneys obtained at the time of harvest were
evaluated in the same way. When 131J RSA was used as a paired
label control to measure non-specific kidney uptake, specific
125J BSA uptake was calculated according to the equation:
''i RSA uptake x plasma 125j BSA at sampling
plasma ISIj RSA at sampling
Morphologic and immunofluoresence study
Kidney and other tissue specimens for routine light micros-
copy were fixed in Bouin's, and paraffin embedded sections
were stained with hematoxylin and eosin, and periodic acid
Schiff. Samples of kidneys were snap—frozen in liquid nitrogen,
and two-micron—sections were prepared for direct immunoflu-
orescence, using fluorescein isothiocyanate (FITC)-conjugated
anti-BSA, anti-rabbit IgG, anti-rabbit C3, and anti-rabbit fibrin.
Results
Kidney transplantation
The 13 transplants which produced acceptable surgical re-
sults, with well—perfused, normal appearing transplant kidneys
at the time of sacrifice are listed in Table I. Data from the other
nine transplantations could not be interpreted because of throm-
bosis, infarction, acute tubular necrosis or ureteric obstruction
of the transplanted kidney, or because of death of the recipient.
These latter data were not included in the analysis.
Plasma clearance of *J BSA
*1 BSA injected into normal rabbits before or after transplan-
tation had a plasma half—life of several hours during its equlibra-
tion with the intra- and extravascular fluids. In CSS rabbits the
plasma levels of BSA (as measured in TCA precipitates) re-
vealed in most cases that between 40 and 90 percent of the total
injected *J BSA dose was present in the plasma 10 minutes after
injection. In these cases, the one hour and three hour plasma
samples showed a decline in circulating *1 BSA, with 30% to
70% of the *J BSA present being in the form of circulating
immune complexes. In a few cases, however, *1 BSA elimina-
tion was much quicker, with the 10 minute plasma level
showing no more than 15 percent of the total injected dose
remaining; this reflected insufficient antigen dosage and rapid *1
BSA elimination via insoluble antibody—excess complexes.
These insufficient *1 BSA doses are indicated "(a)" in Table 2
and Table 3. The effect of insufficient dose was quantitated in
Tx 5 and Tx 6, in which one half the usual dose was compared
with full dose administration. The markedly decreased kidney
uptake of the smaller dose is apparent (Table 2) and cannot be
explained simply by the time difference (48 vs. 24 hours);
previous turnover studies had indicated a Tl/2 of the renal
immune complexed *1 BSA of about five days [8].
Kidney uptake of *1 BSA
The *1 BSA uptakes in successfully transplanted rabbits are
shown in Table 2. In all cases, irrespective of whether a normal
kidney had been transplanted into a CSS recipient (Group A) or
a CSS kidney into a normal recipient (Group B), the CSS kidney
bound considerably more *1 BSA than did the normal kidney.
In proteinuric CSS kidneys, the 24 hour *1 BSA uptake,
expressed as a ratio of the uptake in the CSS kidney to the
normal kidney in the same rabbit, ranged from 4.3 to 17.5 in
Group A, and from 17.5 to 289 in Group B. This ratio is seen to
slightly underestimate the ratio of specific BSA uptakes in each
Specific 1251 BSA uptake = 1251 BSA uptake —
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Table 1. Protocol of radiolabeled proteins administered
Donor (at time of study) Recipient (at time of study)
Wks of BSA P-80 Wks of BSA P-80
Tx # Type injection (g)a Type injection (g)a
1251 BSA and ''1 RSA to recipient 24 hr before sampling
I Normal CSS 7 6
2 Normal CSSb 5 13
18 Normal CSSC 8 39
7 CSS 10 61 Normal
12 CSS 6 62 Normal
13 CSS 6 4 Normal
19 CSS 8 7 Normale
''i BSA to donor 24 hr before transplant; 125j BSA to recipient 24 hr before sampling
16 CSS 10 15 Normal"
20 CSS 8 95 Normal
17 CSS 8 Il Early CSS"" 5 28
22 Early CSSb 4 41 CSS 8 21
''I BSA and 1251 BSA to recipient 48 hr and 24 hr (respectively before sampling)
5 Normal CSS 7 44
6 Normal CSS 6 20
a The P-80 method measures anti-BSA antibody titer as rg 131j BSA nitrogen precipitated by 1 ml of serum when 80% of the 131j BSA added is
precipitated
b Early, preproteinuric CSS rabbit
Did not receive RSA
d Recipient also received 131j BSA 24 hr before transplant
Table 2. I BSA uptake by kidneys in successfully transplanted rec ipients quantitatcd 24 hours after *1 BSA injection
Uptake (gIg) Uptake (g/g) Uptake ratio
Tx # *1 BSA dose in CSS kidney in normal kidney (CSS/normal)
Group A—CSS recipient with normal Tx kidney
1 15 mg" 0.39 (0.35") 0.09 (0.07") 4.3 (49b)
2 25 mg 0.29" (0,26b) 0.14 (0.12") 2.1 (2.21)
5 150mg 16.23 2.00 8.1
<5 70mg" 1.29" 0.41"
6 95mg 3.18
<6 45 mg" 0.40"
0,63
O.l4l
5.1
2.9">
18 60 mg 38.40 2.19 17.5
Group B—normal recipient with CSS Tx
7 5 mg 7.06 (7.05")
12 2 mg 0.68 (0•67b)
13 I mg 3.18 (3.17")
0.025 (0.020")
0.016 (0015b)
0.011 (0.008")
282 (347")
42 (46")
289 (368")
16 29mg 2.93 0.17 17.5
19 10mg 6.15 0.07 90
20 160 mg 22.89 0.84 27
Group C—transplantation between "early" CSS and CSS
0.33" 4917f 40 mg 16.0522 34 mg 7.81 0.31" 25"
Inadequate "I BSA dose (<15% remaining in circulation after 10 mm)
b "Specific" *1 ESA uptake (rabbits given paired label RSA)
Uptake in "early" CSS kidney (nonproteinuric, less than five weeks injection)
"48 hr uptake result (''1 given 48 hr before sampling)
Uptake ratio is: CSS kidney!' early" CSS kidney
CSS kidney transplanted to "early" CSS recipient
g
"Early" CSS kidney transplanted to CSS recipient
case where the use of paired—labelled RSA permitted this
calculation. The uptake in the transplanted CSS kidneys in
Group B (exposed only to uncomplexed *1 BSA) are compara-
ble to the uptakes in untransplanted CSS kidneys (Group A).
(The uptakes averaged 7.15 rgIg in Group B, and 11.70 gIg in
24 hour kidneys in Group A; these are not different by Mann—
Whitney or Student's (-test.) However, a large range of indi-
vidual variation in uptake by CSS kidneys is evident. The 24
hour *J BSA uptake in normal kidneys averaged 0.013 g per
mg of *J BSA injected in Group A (normal kidneys transplanted
and exposed to anti-BSA and *1 BSA), and 0.007 rg per mg in
Group B (untranspianted normal kidneys); this difference was
not statistically significant (Student's (-test). The higher BSA
uptake ratios (CSS/normal) in Group B as compared to Group A
thus can be explained on the basis of the very small dosage of
I BSA given in four of the six animals in Group B; although the
CSS kidney uptake was similar to that seen in Group A, the
normal kidney uptake was small because of the low dose given.
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Table 3. I BSA uptake by kidneys prior to tran
to post-transplant uptakes
splantation compared
13j BSA to donor
24 hr pre-Tx
.
Uptake in
non-Txed
'25IBSA to
recipient 24 hr
pre-sampling
donor Uptake in
Dose kidney Dose Tx kidney
Tx # mg g/g mg p.glg
16 (CSS to normal) 22a 1.69 2.93
17 (CSS to early CSS) 27 5.75 40 16.05
20 (CSS to normal) 160a 8.69 160 22.89
22 (Early CSS to CSS) 34 0.29 34 0.32
a Inadequate *1 BSA dose (<15% remaining in circulation after 10
mm)b Differences in *1 BSA dose between donor and recipient reflect
differences in body wt; with dose chosen to achieve similar plasma
concentrations assuming a plasma volume of 3.1 mI/kg body wt
This suggested that at very low doses of antigen the selective
localization might be enhanced in the immune complex contain-
ing kidney. It appears, therefore, that this difference in uptake
ratios between Group A and Group B does not indicate any
alteration attributable to potential changes in hemodynamics or
in tissue integrity which might be suspected in the transplanted
kidney. That such transplant—specific effects are not a major
factor in these findings is further suggested by the fact that 131j
RSA uptakes, when expressed per mg injected, are slightly
greater in CSS than normal kidneys, but show no difference
between transplanted and untransplanted kidneys. *J BSA
uptakes and uptake ratios in pre-proteinuric "early" CSS
kidneys (Tx2, Tx17, and Tx22) suggest that the "early" CSS
kidneys bind much less than proteinuric "late" CSS kidneys,
and at best only slightly more than normal kidneys.
Table 3 compares the 24 hour *J BSA uptake of transplanted
CSS kidneys to that of the corresponding untransplanted donor
kidney. In each case *1 BSA uptake is greater in the trans-
planted than in the untransplanted kidney. In Tx16 and Tx20,
this may reflect insufficient 131j BSA dosage in the donor study,
with consequently reduced uptake in the untransplanted kid-
ney. In Tx17, where the recipient had plentiful circulating
anti-BSA antibody (though it was an "early", five week,
non-proteinuric CSS rabbit), the increased BSA binding capac-
ity of the transplanted kidney may reflect the emergence of the
increased phase of binding in this particular rabbit. In previous
studies, the change from low to high uptake as observed in
sequential antigen administration occured rapidly (in less than
one week) preceeding the onset of proteinuria [8]. This putative
mechanism is not evident in Tx22, where the transplanted
kidney was also from an "early", four week, CSS rabbit.
Morphologic and immunofluorescence studies
Light microscopy showed extracapillary proliferative glomer-
ulonephritis in all proteinuric CSS kidneys, and less severe
mesangial proliferative changes in "early" pre-proteinuric CSS
kidneys. Transplanted normal and CSS kidneys showed early
signs of rejection (perivascular cellular infiltration) in kidneys
removed 72 hours after transplantation, but this feature was
only occasionally and minimally present at 48 hours after
transplantation. No other histologic evidence of transplant
rejection was seen. Only in transplants excluded from the study
because of problems was there histologic evidence of infarction
or necrosis of parts of the kidney. Direct immunofluorescence
revealed heavy granular BSA and rabbit IgG deposits along the
glomerular basement membranes in all proteinuric CSS kid-
neys; in "early" CSS kidneys, deposits were much less plenti-
ful and tended to be confined to the mesangium. Fibrin depo-
sition was identified in areas of extracapillary proliferation in
CSS kidneys, and only minimally elsewhere within glomeruli.
Transplanted kidneys were not different by immunofluores-
cence microscopy than untransplanted kidneys.
Discussion
The study clearly demonstrates the importance of intrarenal
factors in the accumulation of *1 BSA in CSS glomerulonephri-
tis. The transplantation protocol created a situation in which the
influences of formation and clearance of circulating immune
complexes could be avoided. The quantitative studies were
supported by the immunofluoresence studies which identified
BSA only along the glomerular basement membrane in loca-
tions identical to that of the previously deposited immune
complexes in the CSS kidneys. The studies suggest that the
intrarenal factors include the dynamic interaction of *1 BSA
with the previously deposited BSA-anti-BSA immune complex
accumulations. The contribution of other intrarenal factors
such as changes in mesangial function cannot be excluded
completely; however, previous studies done in this laboratory
did not support a role for mesangial dysfunction in the CSS
model, since mesangial function assessed by the uptake of
aggregated human IgG was elevated throughout the course of
the daily injection once anti-BSA antibody appears [10].
The use of transplantation, while allowing comparisons
within each animal of a CSS and a normal kidney exposed to the
same plasma load of antigen or immune complexes, has also the
potential disadvantage of uncertain hemodynamics and tissue
oxygenation inherent in any transplantation protocol. Though
all morphologically unsatisfactory kidneys were excluded from
consideration, glomerular filtration rate and renal plasma flow
were not measured in this study and may not have been the
same in transplanted as compared to native (non-transplanted)
kidneys. However, comparison of Group A (kidney trans-
planted from a normal donor to a CSS recipient) and Group B
(kidney transplanted from a CSS donor to a normal recipient)
suggests that BSA uptake was determined largely by the CSS
status of the kidney and the quantity of BSA in the blood-
stream, not by whether the kidney was transplanted or native.
The findings in this study support the concept of continuing
dynamic interaction of antigen and antibody in immune com-
plexes even after the complexes accumulate in tissue sites. As
noted earlier, the interaction of anti-BSA antibody with kidneys
after immune elimination in acute serum sickness and the
dissolution of glomerular immune complexes in CSS by huge
antigen excess support this concept [7, 8, 11]. This idea is also
supported by recent findings that non-dissociable covalent-
ly—linked immune complexes do not persist in the renal tissue
[12] unless the complexes have a charge affinity for the glomer-
ular capillary wall [131.
The relative importance of dynamic interaction of antigen,
antibody and immune complexes in the development of CSS
glomerulonephritis cannot be accurately determined. However,
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the results in the current study suggest that the BSA-binding
capacity of the pre-proteinuric "early" CSS kidney is relatively
minor. The accelerated accumulation of immune reactants in
the natural history of this model at about the time of onset of
proteinuria coincides with the ability of the previously depos-
ited immune complexes to hind circulating free antibody and
antigen (as well as circulating immune complexes) in what may
almost amount to a chain reaction. This may be enhanced by
the increases in avidity of the anti-BSA antibody that occurs at
this same time [8]. The dynamic interaction would take place
during the widely fluctuating levels of antigen and antibody that
characterize the daily injection model of CSS. The overall effect
would be to add to or dissociate from the immune complex
deposits depending on the relative ratios of the different im-
munoreactants present, the avidity of the antibody, and perhaps
the late appearance of anti-idiotypic antibody [14, 15].
In generalizing this concept, another factor which needs to be
kept in mind is the influence of any natural affinity of the antigen
or antibody components of the immune complex for the
polyanionic glomerular capillary wall. These factors include
charge and other physicochemical interactions (including
immunoglobulin). In the case of cationic antigens (or antibod-
ies) or ones purposely chemically modified, alterations in the
free dynamic equilibrium of the antigen—antibody reaction
would be forthcoming [16—22]. The overlap between circulating
immune complex deposition, dynamic interaction of antigen
and antibody, and finally the contribution of planted antigen
mechanisms in models involving administration of foreign sol-
uble antigens into an immune host become extremely difficult to
quantify [23].
The relevance of these findings to the understanding of
naturally occurring glomerulonephritis can only be speculative.
In autoimmune forms of immune complex disease such as
systemic lupus erythematosus, a chronic antigen source (DNA
and other nuclear materials) is assumed. Fluctuations in antigen
and antibody levels certainly occur [24]. In addition, DNA has
been suggested to have affinity for the glomerular basement
membrane and may thereby serve as a planted antigen [25, 26]
or perhaps influence the dynamics of antigen—antibody interac-
tion. Acute exacerbations of this and other types of presumed
immune complex forms of glomerulonephritis may reflect sud-
den shifts in previously stable antigen or antibody levels. For
instance, in the so—called mesangial IgA nephropathy, exacer-
bations of disease attend upper respiratory infections which
may be associated with showers of antigen into the circulation,
antibody depletion, and later anamnestic antibody responses
with renal binding. There is little question that dynamic inter-
action of antigen, presumably antibody, and potentially immune
complexes within the glomeruli in instances of presumed im-
mune complex glomerulonephritis must be included in the
equation when addressing factors responsible for the glomeru-
Iar accumulation of immune reactants.
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